TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
SWBI

Smith & Wesson Brands Inc

Industrials · Aerospace & Defense · listed since 1998

13.30$ +2.1% vs. previous close Closing price · As of: Sep 17, 2026
🔔 Watch stock
Add to watchlist

Assessment

Our Rating

A journalistic assessment by our editorial team at the time of the deep dive — it rates the company, not the entry point. Not investment advice and not a solicitation to buy or sell.

Open questions

The business works in principle, but one material question is open. As long as it stays open, our findings do not carry a quality verdict.

Why this colour

The substance holds: a low-debt balance sheet with $28.2 million of cash plus $5.2 million of securities, the credit line reduced by $60 million in fiscal 2026, $114.2 million of operating and roughly $90 million of free cash flow, a steady 26.9 percent gross margin and a brand with 170 years of history. Nothing supports red: no going-concern doubt, no over-indebtedness, and the largest legal risk fell away when the U.S. Supreme Court dismissed the Mexican suit in June 2025. Three things rule out green. First, demand cyclicality: revenue fell from the boom peak of $1,059.2 million in fiscal 2021 to $474.7 million in fiscal 2025 and earnings briefly to a twentieth; underlying NICS demand was recently flat to declining, and the 2026 recovery came from new products rather than from the market. Second, capital returns: in fiscal 2025 $48.6 million flowed to shareholders while operating cash flow was negative at minus $7.2 million — funded from the credit line. Third, customer concentration: two customers accounted for 24.7 percent of revenue and the top five distributors for 46 percent.

What the thesis turns on

Assessment: Opportunities & Risks

Smith & Wesson is a fundamentally sound, low-debt firearms maker with a strong brand, a real dividend and ongoing buybacks — but the engine of this business, firearms demand, is strongly cyclical and driven by politics and events. From the COVID and unrest boom ($1,059.2 million of revenue in fiscal 2021) the company has fallen back to roughly half; the fiscal 2026 recovery (+10.4 percent) came from new products, not from a new wave of fear. Capital returns in fiscal 2025 even ran past a negative cash flow. The share has more than doubled off its low and leads the recovery. A solid, cash-returning cyclical without a clear margin of safety — no reason for caution, but no bargain either. Not investment advice.

Balance sheet & substance

Low debt: about $28.2 million of cash plus $5.2 million of securities, the credit line reduced by $60 million in fiscal 2026. Operating cash flow back to $114.2 million with roughly $90 million free. Profitable across the whole cycle. A solid base that carries the downturn.

Capital returns

An uninterrupted quarterly dividend since 2020 (about $0.52 per share a year, yielding roughly 3.4 percent) plus ongoing buybacks that have meaningfully shrunk the share count. Real and shareholder-friendly — but in the trough year of fiscal 2025 funded past a negative operating cash flow, so it is tied to the cycle.

Demand cyclicality

The core reservation: revenue fell from the COVID and unrest boom ($1,059.2 million in fiscal 2021) to roughly half, and earnings briefly to a twentieth. The fiscal 2026 recovery (+10.4 percent) came from new products while underlying NICS demand was flat to declining. A politics- and event-driven cycle nobody can schedule.

Law & reputation

Lawsuits come with the business: three product liability cases plus six further claims, and a quantified contract dispute ($18.6 million, trial January 2027). But the biggest item fell away — the Mexican government's multi-billion-dollar suit was dismissed by the U.S. Supreme Court in June 2025, and the PLCAA remains the essential liability shield. Real, but bounded.

Valuation & price

The price-to-earnings ratio of around 38 overstates the expense (earnings trough); a forward multiple around 12, EV/EBITDA around 11.6 and price-to-sales around 1.3 are moderate but no bargain. The price has run ahead of the recovery: more than doubled from the 52-week low, near the yearly high.

Worth Noting

Identity and legal form: Smith & Wesson Brands, Inc. — incorporated in Nevada, operating headquarters in Maryville, Tennessee (CIK 0001092796, ISIN US8317541063). A pure firearms maker since the outdoor division (American Outdoor Brands) was spun off in August 2020. The fiscal year ends April 30. Demand proxy: NICS background checks.

Special-situation screening (EDGAR full index, CIK 1092796): no pending takeover, no strategic review, no rights plan, no active 13D campaign (only passive SC 13G/A); routine 8-K, Form 3/4 and exempt solicitations (ESG activism, common at firearms makers). Insiders hold about 2.3 percent, institutions about 58 percent.

Price and valuation figures are dated to mid-July 2026; analyses are evergreen and daily prices are not a buying argument. The market capitalisation of roughly $690 million refers to about 44.7 million shares outstanding.

The six-year charts are built from the SEC XBRL company-concept series (revenue, net income, dividends paid, share repurchases, operating cash flow), so every bar can be traced back to a filed annual report.

AI classification: neutral. No material AI reference in the filings reviewed; the only mention is a generic risk factor on internal AI use (Item 1A of the fiscal 2026 10-K) with no specific link to the firearms business — no AI revenue source, no operational AI use, no concrete AI threat to the demand model.

Stock Watch

This analysis is as of August 29, 2026. Stock Watch will tell you what's changed at SWBI since then.

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Price history

Chart

Interactive price chart (TradingView).

52-week range: 8.20 $ to 16.70 $ · Last price: 13.30 $ (As of: September 17, 2026)

Key figures

Key figures at a glance

Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.

Basics

Market Cap ?The value of the entire company on the market: share price times total shares outstanding. 0.6$B
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 45m
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 97.8%
Beta ?Volatility versus the overall market: 1 = moves like the market, 2 = twice as much, under 1 = calmer than the market. 0.9

Performance

Perf. 1M ?Price performance over the last month. 1.20%
Perf. 3M ?Price performance over the last 3 months. 5.00%
Perf. 6M ?Price performance over the last 6 months. 54.20%
YTD Performance (%) ?Price performance since the start of the year (Year to Date). 70.50%
52-Week-High Distance ?How far the price sits below its highest point over the last 52 weeks. 0% means the stock is at its year high. -10.7%
Perf. 1Y ?Price performance over the last 12 months. 49.40%
Perf. 3Y ?Price performance over the last 3 years. 33.62%
Perf. 5Y ?Price performance over the last 5 years. -23.50%
Perf. 10Y ?Price performance over the last 10 years. -21.67%
Perf. Since Inception ?Price performance since the first available trading day (11/06/1998) — with a complete history, that is since the IPO. 1,718.31%

Technical Indicators

MA 38 Days ?Moving average of the last 38 trading days: the smoothed price path. A price above it signals short-term strength. 13.80$
MA 50 Days ?Moving average of the last 50 trading days — the most widely watched medium-term trend line. 14.10$
MA 200 Days ?Moving average of the last 200 trading days — the dividing line between a long-term uptrend and downtrend. 13.40$
RSI (14) ?Relative Strength Index over 14 days, scale 0 to 100: above 70 counts as overbought, below 30 as oversold. A hint on timing, not a verdict on the company. 47.3
Volatility 30 Days ?Price swings over the last 30 trading days, annualized. The higher the value, the more the price fluctuates. 28.6%
Volatility 250 Days ?Price swings over the last 250 trading days (roughly one market year), annualized. 42.1%

Calculated from the price history · as of 09/18/2026

Valuation

P/E ?Price-to-earnings ratio: how many years of profit does the stock cost? The lower, the cheaper the valuation. No earnings means no P/E.
Forward P/E ?P/E based on expected earnings for the next 12 months instead of past earnings — analysts' bet on the future. 11.8
PEG ?P/E divided by expected earnings growth: puts valuation in relation to growth. Around 1 is considered fair, well above that is pricey. 0.8
P/B ?Price-to-book ratio: market value relative to book equity.
P/S ?Price-to-sales ratio: market value divided by annual sales. Important for companies that aren't (yet) profitable. 1.1
EV/EBITDA ?Enterprise value including debt (EV) relative to operating profit before depreciation and amortization (EBITDA) — more comparable than P/E because debt counts too. Extreme values arise when EBITDA is near zero. 9.4
Price/FCF ?Market value divided by free cash flow: how many years of freely available cash does the stock cost? More honest than P/E because cash flow is harder to dress up. 6.2

Profitability

Gross Margin ?Gross margin: what's left of sales after only direct production costs are deducted — the product's pricing power. 26.9%
EBIT Margin ?EBIT margin: operating profit as a percentage of sales — the earning power of the core business before interest and taxes.
Net Margin ?Net margin: what's left of sales as profit after ALL costs, interest, and taxes. 4.4%
Return on Equity ?Return on equity: how much profit does the company generate per year on shareholders' equity? 4.9%
Return on Assets ?Return on assets: how much profit the company generates from its total assets (equity and debt combined). 3.8%

Balance Sheet & Safety

Equity Ratio ?Equity ratio: equity as a share of total assets. The higher, the more resilient the balance sheet.
Debt/Equity ?Leverage ratio: financial debt divided by equity. Under 1 is generally seen as solid; negative values mean negative equity.
Altman Z″ ?Edward Altman's bankruptcy early-warning score. We use the Z″ variant, built from four balance-sheet ratios — it is designed for service companies and non-manufacturers and uses book value instead of market value. On that scale: below 1.1 = danger zone, 2.6 and up = safe zone, in between a grey area. Because the classic Altman Z is calculated differently, the two numbers are not directly comparable. The formula does not fit banks, insurers, or real-estate stocks. fortress balance sheet 11.04
Piotroski ?Balance-sheet health check by Joseph Piotroski: 9 yes/no criteria on profit, cash flow, leverage, and efficiency. 7+ is very solid, under 3 is a red flag. 7 out of 9

Growth

Sales Growth Last Quarter ?Sales growth in the most recently reported quarter versus the same quarter a year ago (YoY). 26.70%
EPS Growth Last Quarter ?Growth in earnings per share in the most recently reported quarter versus the same quarter a year ago (YoY). 86.70%
Sales Growth (Year) ?Sales growth in the last fiscal year versus the year before. 10.36%
Forward Sales Growth ?Sales growth analysts expect over the next 12 months — an estimate, not a guarantee. -100.00%
Forward EPS Growth ?Earnings-per-share growth analysts expect over the next 12 months — an estimate, not a guarantee.

Dividend

Dividend Yield ?Annual dividend divided by the current price: what percentage of your investment comes back as a payout each year. 3.95%
Dividend Per Share (TTM) ?Sum of dividends paid per share over the last 12 months. 0.52$
Payout Ratio ?Share of profit paid out as dividends. Over 100% means the company is paying out more than it earns — not sustainable long-term. 96.3%
Years Without a Cut ?How many years in a row the dividend hasn't been cut — a measure of reliability. 5Years
Increase Streak ?How many years in a row the dividend has been raised — the gold standard for dividend payers. 5Years

Quality & Screener

Stage ?Weinstein phases 1 through 4: 1 = basing, 2 = uptrend (the only buy phase), 3 = topping, 4 = downtrend. Measured against the 30-week line. 2
RS Rating ?Relative strength from 1 to 99: an RS of 95 means the stock has outperformed 95% of all stocks. 86
EPS Rating ?Earnings growth rating from 1 to 99 versus all stocks — high values mean above-average earnings growth. 84
Fundamental Rating ?Our own Fundamental Rating: 0 to 100 points with an A+ to F grade. 50 points is the average across the universe, 100 the best possible score. It scores growth, earnings surprises, analyst estimates, margins, cash flow, and balance-sheet safety — every stock percentile-ranked against all others. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below. B (63 out of 100)

Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.

Comparison

Industry comparison

The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.

Industry: Aerospace & Defense

Industry comparison
Company Market cap ($B) P/E EV/EBITDA Gross Margin % EBIT Margin % Sales Growth (Year) % Perf. 1Y %
Smith & Wesson Brands Inc SWBI 0.6 9.4 26.9 10.4 49.4
Space Exploration Technologies Corp. SPCX 1,172.1 511.6 51.9
GE Aerospace GE 326.7 40.1 27.6 31.1 20.2 18.5 8.8
RTX Corporation RTX 254.2 36.5 18.5 20.3 13.2 9.7 24.1
The Boeing Company BA 155.3 78.7 25.5 4.7 1.7 34.5 -8.2
Lockheed Martin Corporation LMT 124.1 26.0 13.6 11.8 11.0 5.7 16.7
General Dynamics Corporation GD 96.7 22.8 15.1 15.4 10.5 10.1 11.4
Howmet Aerospace Inc HWM 90.3 52.0 34.8 36.0 28.2 11.1 22.0
Northrop Grumman Corporation NOC 73.6 16.6 11.8 20.1 11.7 2.2 -7.7
Median of companies shown 124.1 36.5 18.5 20.3 11.7 10.2 14.0

Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →

Fiscal years

Annual Figures

Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.

Revenue, operating income and net income per fiscal year $M

Revenue Operating income Net income

2017 · Revenue: 903 $M 2017 · Operating income: 200 $M 2017 · Net income: 128 $M 2018 · Revenue: 607 $M 2018 · Operating income: 27 $M 2018 · Net income: 20 $M 2019 · Revenue: 638 $M 2019 · Operating income: 38 $M 2019 · Net income: 18 $M 2020 · Revenue: 678 $M 2020 · Operating income: 50 $M 2020 · Net income: -61 $M 2021 · Revenue: 1,059 $M 2021 · Operating income: 320 $M 2021 · Net income: 252 $M 2022 · Revenue: 864 $M 2022 · Operating income: 252 $M 2022 · Net income: 194 $M 2023 · Revenue: 479 $M 2023 · Operating income: 48 $M 2023 · Net income: 37 $M 2024 · Revenue: 536 $M 2024 · Operating income: 45 $M 2024 · Net income: 40 $M 2025 · Revenue: 475 $M 2025 · Operating income: 24 $M 2025 · Net income: 13 $M 2026 · Revenue: 524 $M 2026 · Operating income: 29 $M 2026 · Net income: 18 $M
2017201820192020202120222023202420252026
Annual Figures
Fiscal Year Revenue ($M) EBIT ($M) Net Income ($M) EPS ($) Operating Cash Flow ($M) Equity ($M) Total Assets ($M)
2017 903 200 128 2.25 124 393 788
2018 607 27 20 0.37 62 422 745
2019 638 38 18 0.33 57 444 767
2020 678 50 -61 -1.11 95 387 729
2021 1,059 320 252 4.55 315 266 446
2022 864 252 194 4.08 138 361 497
2023 479 48 37 0.80 17 385 541
2024 536 45 40 0.86 107 400 577
2025 475 24 13 0.30 -7 372 560
2026 524 29 18 0.41 114 377 513

Quarters

Quarterly Figures

Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2025: Q1 · 115.9 $M Q1 2025: Q2 · 140.8 $M Q2 2025: Q3 · 85.1 $M Q3 2025: Q4 · 124.7 $M Q4 2026: Q1 · 135.7 $M Q1 2026: Q2 · 178.4 $M Q2 2026: Q3 · 112.6 $M Q3

Source: fundamental data

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2025: Q1 0.04 -78.10 116 -15.70 1.40 -10 -16
2025: Q2 0.22 -61.30 141 -11.60 6.90 41 34
2025: Q3 -0.08 85 -3.70 -4.00 -8 -12
2025: Q4 0.04 -53.40 125 -3.90 1.50 27 32
2026: Q1 0.08 123.50 136 17.10 2.80 21 17
2026: Q2 0.36 63.50 178 26.70 9.10 75 70
2026: Q3 0.06 175.00 113 32.30 2.30 -9 -21

What Do These Terms Mean?

EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Compare with other stocks →

Screening

Appears in These Scanners

This stock currently matches 15 of our scanner strategies — each hit links to the scanner.

Growth

Quality & Balance Sheet

Aktien.Guide

Breakout & Setup

Dividends

Earnings & Surprises

Momentum & Trend

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners

Outlook

Analysts & Price Target

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Consensus Sell 1 = Strong buy … 5 = Strong sell
Analyst Ratings 3
Price Target (average) 17.25$
Distance to price 29.7% The price target sits 29.7% above the current price.

Distribution of Recommendations

Strong Buy 2
Buy 0
Hold 1
Sell 0
Strong Sell 0

Estimates by Fiscal Year

Estimates by Fiscal Year
Fiscal Year EPS Estimate ($) EPS Range ($) Revenue Estimate ($M) Expected Growth Analysts
04/30/2027 0.55 0.55 – 0.55 559 34.2% 1
04/30/2028 0.60 0.60 – 0.60 572 9.1% 1

Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.

Valuation

What is priced in?

Instead of guessing what the stock is worth, we turn the question around: what free cash flow growth has to happen for today’s market value to add up? The assumptions behind it can be moved.

Today’s market value implies roughly -6.3% growth in free cash flow per year over ten years (assumptions: discount rate 10.0%, terminal growth 2.5%).

What is priced in?
Free cash flow (last twelve months) $82.0M
Market cap $603.0M
Free cash flow in year ten $42.9M
Terminal value as a share of market value 37.5%

For comparison: over the past five years free cash flow shrank by 20.9% per year.

It shows which assumption is built into today’s price, not whether that assumption will hold. Every assumption can be changed with the sliders; the figures move with them.

A simplified model calculation — not a forecast and not a recommendation.

AI classification

AI Rating

Neutral

Geprüft am 10.07.2026 gegen den Geschäftsbericht (10-K) Geschäftsjahr 2026 (bis 30.04.2026, eingereicht 17.06.2026), den 10-K Geschäftsjahr 2025 und die vier jüngsten Quartalsberichte (10-Q). In den ausgewerteten SEC-Filings von Smith & Wesson Brands findet sich kein wesentlicher KI-Bezug: keine KI-Umsatzquelle, kein dokumentierter operativer KI-Einsatz und kein konkretes KI-Geschäftsrisiko für das eigene Modell. Die einzige nennenswerte KI-Erwähnung ist ein generischer Risk-Factor im Item 1A des 10-K 2026 („Our use of artificial intelligence, or AI, may adversely impact our business“), der ausschließlich allgemeine Gefahren der internen KI-Nutzung durch Mitarbeiter beschreibt (Abfluss vertraulicher Informationen, IP-Missbrauch, fehlerhafte Ergebnisse/Bias, Wettbewerbsnachteil bei zu langsamer Adoption). Nach dem Kriterienkatalog ist das eine Boilerplate-Risk-Floskel ohne konkreten Bezug zum Waffengeschäft — KI bedroht die Nachfrage nach Handfeuerwaffen und Gewehren nicht, treibt sie nicht und wird nicht verkauft. Der Quartalsbericht Q3 (per 31.01.2026) enthält gar keinen KI-Treffer. Damit bleibt es beim dokumentierten Negativ-Befund: neutral.

View the full file — quotes, sources, reviewed filings

Filings Reviewed: 10-K 2026-06-17 · 10-K 2025-06-20 · 10-Q 2026-03-05 · 10-Q 2025-12-04 · 10-Q 2025-09-04 · 10-Q 2025-03-06

Rated on July 10, 2026 · How the Rating Is Built

Growth

Growth Score

Ten checks against the annual reports — each one passed counts a point.

4 of 10 Weak growth
  • Revenue grows by more than 15% a year over three years 3.0%
  • More than 10% revenue growth is expected for the coming year -100.0%
  • Share count grows by less than 3% a year -0.7%
  • Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 27.6%
  • Gross margin at 40% or higher and without meaningful erosion 26.9%
  • Goodwill from acquisitions does not grow faster than revenue 3.7%
  • Net debt below twice EBITDA 0.3 x EBITDA
  • Operating cash flow covers the profits of the last three years 142 m
  • Return on capital at 15% or higher, or up versus two years ago 6.7%
  • Insiders hold at least 10% or are net buyers 2.3%

A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail

Quality check

AAQS

4/10

The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).

  • Sales growth 10Y > 5% -5.9%
  • Exp. sales growth 3Y > 5% 4.5%
  • EBIT growth 10Y > 5% -19.2%
  • Exp. EBIT growth 3Y > 5% 21.2%
  • Net debt < 4x EBIT 0.7x
  • EBIT positive, 10Y straight 10
  • Max. EBIT decline < 50% 92.5%
  • Return on equity > 15% 5.2%
  • ROCE > 15% 6.7%
  • Expected return > 10% 39.4%

View stocks with the full AAQS score · Read the methodology at AlleAktien

Source: fundamental data

The company

About the Company

Smith & Wesson Brands, Inc. entwirft, fertigt und verkauft weltweit Schusswaffen.

Employees
1,378
Headquarters
Maryville, TN
Address
1852 Proffitt Springs Road, 37801 Maryville, United States
Phone
800 331 0852
IPO Date
11/09/1998
ISIN
US8317541063
Stock Split
1301:1000 on 08/25/2020

Management

Management
Name Title Birth Year
Mark Peter Smith President, CEO & Director 1976
Deana L. McPherson CPA Executive VP, CFO, Treasurer & Assistant Secretary 1970
Kevin Alden Maxwell Senior VP, General Counsel, Chief Compliance Officer & Secretary 1976
Kyle O. Tengwall Chief Marketing Officer & VP of Corporate Strategy 1972

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Filings

Company Filings (8-K)

An 8-K is the filing a US company must use to disclose material events immediately — takeovers, changes at the top, major contracts or payment troubles, for instance. The links open the original document at the US Securities and Exchange Commission (SEC).

  • 09/16/2026 SMITH & WESSON BRANDS, INC. (SWBI): Submission of Matters to a Vote of Security Holders SEC ↗
  • 09/03/2026 SMITH & WESSON BRANDS, INC. (SWBI): Results of Operations and Financial Condition; Financial Statements and Exhibits SEC ↗
  • 07/15/2026 SMITH & WESSON BRANDS, INC. (SWBI): Regulation FD Disclosure; Financial Statements and Exhibits SEC ↗

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?